Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages

American Journal of Reproductive Immunology

Volumn 38, Issue 1, 1997, Pages 46-54

  Deshpande, Rohini ^a   Khalili, Houman ^a   Pergolizzi, Robert G ^a   Michael, Sandra D ^b   Chang, Ming Dery Y ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b BINGHAMTON UNIVERSITY   (United States)

Author keywords

IL 1; IL 6; Macrophages; NFkB; TNF

Indexed keywords

CYTOKINE; ESTRADIOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; DOWN REGULATION; FEMALE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030751549     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1997.tb00275.x     Document Type: Article

References (57)

1. Bathcelor JR. Hormonal control of antibody formation. In Regulation of the Antibody Response. B Cinader (led.) Charles C. Thomas, Springfield. 1968, pp 276-293.
2. Cohn DA. High sensitivity to androgen as a contributing factor in sex difference in the immune response. Arthritis Rheum 1979; 22:1218-1233.
3. Cohen JHM, Danel L, Cordier G, Saez S, Revillard JP. Sex steroids in peripheral T cells: Absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells. J Immunol 1983; 131:2767-2771.
4. Danel L, Menouni M, Cohen JHM, Magaud JP, Lenoir G, Revillard JP. Saez S. Distribution of androgn and estrogen receptors among lymphoid and hematopoetic cell lines. Leuk Res 1985; 9:1373-1378.
5. Paavonen T, Andersson L, Adlercreutz H. Sex hormone regulation of in vitro immune response. J Exp Med 1981; 154:1935-1945.
6. Screpanti I, Meco D, Morone S, Gulino A, Mathieson B J, Frati L. In vivo modulation of the distribution of thymocyte subsets: Effects of estrogen on the expression of different T cell receptor Vβ gene families in CD4,CD8 thymocytes Cell Immunol 1991; 134:414-426.
7. Okuyama R, Abo T, Seki S, Ohketi T, Sugiura K, Kusumi A. Kumagai K. Estrogen administration activates extrathymic T cell diffrentiation in the liver. J Exp Med 1992; 175:661-669.
8. Pacifici R, Brown C, Puschek E, Friedrich E, Stapolsky E, Magio D, McCracken R, Avioli LV. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 1991; 88:5134-5138.
9. Cantatore FP, Loverro G, Ingrosso AM, Lacanna R, Sassanelli E, Selvaggi L, Carrozzo M. Effect of oestrogen replacement on bone metabolism and cytokine in surgical menopause. Clin Rheumatol 1995; 14:157-160.
10. Bismar H, Diel I, Ziegler R, Pfeilschifter J. Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement. J Clin Endocrinol 1995; 80:3351-3355.
11. Michael SD, Chapman JC. The influence of the endocrine system on the immune system. Rep Immunol 1990; 10:215-233.
12. Cho T-C, Van Alten PJ, Walter BRJ. Steroid sex hormones and macrophage function: Modulation of reactive oxygen intermediates and nitrite release. Am J Reprod Immunol 1994; 32:43-52.
13. De M, Sanford TR, Wood GW. IL-1, IL-6 and TNF-α are produced in the mouse uterus during the estrous cycle and are induced by estrogen and progesterone. Dev Biol 1992; 154:291-305.
14. Lapp CA, Thomas ME, Lewis JB. Modulation by progesterone of interleukin-6 production by gingival fibroblasts. J Periodontol 1995; 66:279-284.
15. McLachlan JA, Serkin CD, Bakouche O. Dehydroepiandrosterone modulation of lipopolysaccaride-stimulted monocyte cytotoxicity. J Immunol 1996; 156:328-335.
16. Polan M, daniele A, Kuo A. Gonadal steroids modulate human monocyte interleukin-1 (IL-1) activity. Fertil Steril 1988; 49:964-968.
17. Chaudhary L, Spelsberg T, Riggs B. Production of various cytokines by normal human osteoblast like cells in response to interleukin-1βand tumor necrosis factor-α: lack of regulation by 17β-estradiol. Endocrinology 1992; 130:2528-2534.
18. Horowith M. Cytokines and estrogen in bone: Anti-osteoporotic effects. Science 1993; 260:626-628.
19. Ray A, Prefontain K, Ray P. Down-modulation of interleukin-6 gene expression by 17β-estradiol in the absence of high affinity DNA binding by estrogen receptor. J Biol Chem 1994; 269:12940-12946.
20. Tabibzadeh SS, Santhanam U, Sehgal PB, May LT. cytokine-induced production of IFNβ2/IL-6 by freshly explanted human endometrial stromal cells. J Immunol 1989; 142:3134-3139.
21. Hermann F, Martelsmann R. Polypeptides controlling hematopoetic cell development and activation. Blood 1989; 58:117-120.
22. Nakano M, Saito S, Nakano Y, Yamasu H, Matsuura M, Shinomiya H. Intracellular protin phosphorylation in murine peritoneal macrophages in response to bacterial lipoplysaccharide (LPS). Immunobiology 1993; 187:272-282.
23. Taniguchi T. Regulation of cytokine gene expression. Annu Rev Immunol 1988; 6:439-464.
24. Philips A, Chalbos D, Rochefort H. Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. J Biol Chem 1993; 268:14103-14108.
25. Chang MDY, Pollard JW, Khalili H, Goyert S, Diamond B. Mouse placental macrophages have a decreased ability to Present antigen. Proc Natl Sci USA 1993; 90:462-466.
26. Lattime EC, Stutman O. Tumor growth in vivo selects for resistance to tumor necrosis factor. J Immunol 1989; 143:4317-4323.
27. Van Oers MH, Vab Der Hyden PAM, Aarden LA. IL-6 in serum and urine of renal transplant recipients. Clin Exp 1988; 71:314-319.
28. Wynn TA, Eltoum I, Cheever AW, Lewis FA, Gause WC, Sher A. Analysis of cytokine mRNA expression during primary granloma formation induced by eggs of schistosoma mansoni. J Immunol 1993; 151:1430-1440.
29. Allen RD, Staley TA, Sidman CL. Differential cytokine expression in acute and chronic murine graft-versus-host-disease. Eur J Immunol 1993; 23:333-337.
30. Kennedy MK, Torrance DS, Picha KS, Mohler KM. Analysis of cytokine mRNA expression in the central nervous of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 1992; 149:2496-2505.
31. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acid Res 1983; 11:1475-1489.
32. Bradford M. A rapid and snsitive method for the quantitation of microgram quantities of utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
33. Jamieson C, McCaffrey PG, Rao A, Sen R. Physiological activation of T cells via the T cell receptor induces NFkB. J Immunol 1991; 147:416-420.
34. Wright S, Ramos R, Tobias P, Ulevitch R, Mathison J. CD14, a receptor for complexs of lipopolysaccharide and LPS binding protein. Science 1990; 249:1431-1433.
35. Lynn W, Liu Y, Golenbock D. Neither CD14 nor serum is absolutely necessary for activation of mononuclear phagocytes by bacterial lypopolysaccharide. Infect Immun 1993; 61:4452-4461.
36. Ferrero E, Jiao D, Tsuberi BZ, Tesio L, Rong GW, Haziot A, Goyert SM. Transgenic mice expressing human CD14 are hypersensitiv to lipopolysaccharide Proc Natl Acad Sci USA 1993; 90:2380-2384.
37. Novogrodsky A, Vanichkin A, Patya M, Gazit A, Osherov X, Levitzki A. Prevntion of lipopolysaccharid-induced lethal toxicity by tyrosine kinase inhibitors. Science 1994; 264:1319-1321.
38. Xu H, Gonzalo JA, Pierre YS, Williams IR, Kupper TS, Cotran RS, Springer TA, Gutierrez-Ramos J: Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J Exp Med 1994; 180:95-109.
39. Martin C, Dorf M. Interleukin-6 production by murine macrophage cell lines P388D1 and J774A.1:Stimulation requirements and kintics. Cell Immunol 1990; 128:555-568.
40. Shimizu H, Mitomo K, Watanabe T, Okamoto S, Yamamoto K. Involvement of a NFkB-like transcription factor in the activation of the intrleukin-6 gene by inflammatory lymphokines. Mol Cell Biol 1990; 10:561-568.
41. Shakov AN, Collart MA, Vassalli P, Nedospasov SA, Jongeneel CV. Kappa B-type enhancers are involved in Lipopolysaccharide-mediated transcriptional activation of tumor necrosis factor alpha gene in primary macophages. J Exp Med 1990; 171:35-47.
42. Grilli M, Chiu JS, Lenardo MJ. NF-kB and Rel: Participates In a multiform transcriptional regulatory system. Int Rev Cytol 1993; 143:1-62.
43. Mackman N, Brand K, Edgington TS. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein-1 and nuclear factor kappa B binding sites. J Exp Med 1991; 174:1517-1526.
44. Clark BD, Collins KI, Gandy MS, Webb AC. Genomic sequences for human prointerleukin 1β: possible evolution from a reverse transcribed prointerleukin IL la gene. Nucleic Acid Res 1986; 20:7877-7914.
45. Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NFkB transcription factor. Mol Cell Biol 1990; 10:2327-2334.
46. Mukaida N, Shiroo M, Matsushima K. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 1989; 143:1366-1371.
47. Nishizawa M, Nagata S. Regulatory elments responsible for inducible expression of the granulocyte colony-stimulating factor gene in macrophages.Mol Cell Biol 1990; 10:2002-2011.
48. Pioli G, Basini G, Pedrazzoni M, Musetti G, Ulietti V, Bresciani D, Villa P, Bacchi A, Hughes D, Russell G, Passeri M. Spontaneous release of intrleukin-1 and interleukin-6 by periphral blood mononuclear cells after oophorectomy. Clin Sci 1992; 83:503-507.
49. Polan ML, Kuo A, Loukides J, Bottomly K. Cultured human luteal peripheral monocytes secrete increased levels of interleukin-1. J clin endocrinol Metab 1990; 70:480-484.
50. Girasol G, Jilka R, Passeri G, Boswell S, Boder G, Williams D, Manolagas S. 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 1992; 89:883-891.
51. Hu SK, Mitcho Y, Rath N. Effect of estradiol on intrleukin 1 synthesis by macrophages. Int J Immunopharmacol 1988; 10:247-252.
52. Kovacs EJ, Radzioch D, Young H, Varesio L. Differential inhibition of IL-1 and TNF-α mRNA expression by agents which block second messenger pathways in murine macrophages. J Immunol 1988; 141:3101-3105.
53. Shirakawa F, Mizel S. In vitro and nuclear translocation of NF-kappa B catalyzed by c AMP-dependent protein kinase and protein kinase C. Mol Cell Biol 1989; 9:2424-2430.
54. Stein B, Yang MX. Repression of the interleukin-6 promoter by receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol 1995; 15:4971-4979.
55. Beutler B, Cerami A. The biology of cachectin/TNF-α primary mediator of the host response. Annu Rev Immunol 1989; 7:625-655.
56. Waage A, Halstensen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; 1:355-357.
57. Goldfeld AE, Maniatis T. Coordinate viral induction of tumor necrosis factor alpha and interferon beta in human B cells and monocytes. Proc Natl Acad Sci USA. 1989; 86:1490-1496.